Studiencode: 194-00
| Institution: | Quitiles - Outcome Europe | Auftraggeber: | Merck Sharp & Dohme Corp. |
| Titel der NIS: | A Prospective Observational Study to Evaluate the Relationship between Disease State and Change in Quality of Life in Ankylosing Spondylitis Patients treated with Remicade (infliximab) or Simponi (golimumab) | ||
| Ziel der NIS: | To develop an algorithm, using baseline (or pre-anti-TNF treatment) parameters (demographic, clinical, AS severity) that predicts change in HRQoL, as measured by the physical component summary (PCS) of the Short Form 36 (SF-36), in AS patients treated with infliximab or golimumab. |
||
| Anzeige am: | 28.05.2013 | Geplanter Beginn: | 01.03.2013 | Geplantes Ende: | 30.06.2014 |
| Angezeigtes Ende der NIS am: 18.06.2015 | |||||
| Art des Dokuments | |
|---|---|
| Beobachtungsplan, NIS 233 | pdf 267KB |
